These are lot-specific recalls, not a blanket statement that metoprolol or enalapril has been pulled from the market. According to FDA Enforcement Report records: Metoprolol Succinate Extended-Release Tablets, USP 25 mg Recalling firm: Ascend Laboratories, LLC Manufacturer listed in the product description: Alkem Laboratories Ltd., India Distributor: Ascend Laboratories, LLC NDC: 67877-590-01 Lot: 25140859 Expiration: January 2027 Quantity: 17,304 100-count bottles Reason: failed dissolution specifications Recall number: D-0547-2026 Enalapril Maleate Tablets, USP 20 mg Recalling firm: JB Chemicals and Pharmaceuticals Ltd Manufacturer listed in the product description: Unique Pharmaceutical Laboratories, a division of J.B
Oral tirzepatide drops are non-FDA-approved, compounded formulations that claim to deliver tirzepatidea prescription injectable medicationwithout the use of needles
Additionally, individual patient factorssuch as cardiovascular health, psychiatric history, and treatment goalsplay a critical role in determining safety
This guide explores how antioxidants work, their benefits, and how to choose the best supplements
A ratio of fluorescence intensities measured at 340 nm and 380 nm was calculated minus the background fluorescence